Discussion
Treatment with Evrysdi (risdiplam) was associated with stable overall motor function and improved upper limb function in a small Chinese study of 15 people with spinal muscular atrophy (SMA). Upper limb function scores increased in the type 2 group and the combined types 3–4 group, although neither change…